IMUX Immunic Therapeutics Buxgalteriya kapitallashuvi

Ommaviy kompaniya Immunic Inc (IMUX) logotipi

Immunic, Inc. (IMUX) faoliyati xalqaro siyosiy risklar hamda patentlar yoki xomashyo ta'minoti bilan bog'liq murakkabliklar tufayli cheklangan. Kompaniyaning bozor kapitalizatsiyasi 0.13 miqdorini tashkil etadi, foyda esa davlat xaridlari hamda autoimmun patologiyalarni davolash bo'yicha sanoat yetakchilari bilan tuzilgan kelishuvlarga asoslangan. Aktiv qiymatining ushbu grafigi shiddatli ilmiy va texnologik raqobat sharoitida an'anaviy inyeksiyalarga qulay tabletka muqobillarini yaratayotgan biznes dinamikasini namoyish etadi.

IMUX Immunic Balans kapitallashuvi (04.07.2022 - 27.10.2026)

Immunic Inc (IMUX) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Immunic, Inc.|IMUX - Konsensus maqsadli narx
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Immunic, Inc.|IMUX - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning balans qiymati Immunic|IMUX - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor qiymati immunic-therapeutics.com|IMUX - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Immunic, Inc.|IMUX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Immunic, Inc.|IMUX - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Immunic, Inc.
Fundamental baholash:IMUX - Immunic
immunic-therapeutics.com yetakchi tovari

Immunic, Inc. (IMUX) kompaniyasida dori vositalarini ishlab chiqish jarayoniga ESG standartlari va bioetikaning integratsiyalashuvi uning kitob kapitalizatsiyasi dinamikasida aks etgan bo'lib, bu ichki resurslarning barqarorligini tasdiqlaydi. Ushbu ko'rsatkich sof aktivlarning majburiyatlardan ayirma yig'indisi sifatida hisoblanadi va kompaniyaning haqiqiy ichki qiymatini belgilaydi; biroq, bozor likvidligining pasayishi fonidagi o'sish aldovchi bo'lishi mumkin va investor uchun yashirin xatarlardan signal beradi.

Immunic, Inc. raqobatchilari tahlili

argenx BVBA (ARGX) - Balans kapitallashuvi|Kompaniyaning sof aktivlari BioNTech SE|ABVX (ABIVAX) - Buxgalteriya kapitallashuvi|Kompaniyaning balans qiymati ADMA Biologics, Inc. ADMA|Sof aktivlar qiymati Protagonist Therapeutics, Inc.|Immunovant Corp (IMVT) - Balans kapitallashuvi|Kompaniyaning buxgalteriya qiymati Kiniksa Corp (KNSA)|Balans kapitallashuvi GRFS (Grifols, S.A.)|adaptivebiotech.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Celldex Therapeutics, Inc. (CLDX)|AUPH: Kompaniyaning buxgalteriya qiymati|BCRX (BioCryst Pharmaceuticals Inc) - Kompaniyaning balans qiymati|Vera Corp (VERA) - Kompaniyaning sof aktivlari|DNTH (Dianthus Therapeutics) - Balans kapitallashuvi|Balans kapitallashuvi pharvaris.com (PHVS)|AbCellera Bio (ABCL) - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati Tourmaline Bio Inc (TRML)|Balans kapitallashuvi PGEN|Pharming Corp - Biznesning balans bahosi|NKTR: Kompaniyaning balans qiymati|UPB: Kompaniyaning sof aktivlari|ZBIO (Zenas Biopharma) - Kompaniyaning balans qiymati|Kompaniyaning sof aktivlari Immunome Inc|GOSS (Gossamer Corp) - Kompaniyaning sof aktivlari|Balans kapitallashuvi KALV|Kompaniyaning balans qiymati Septerna Inc SEPN|Buxgalteriya kapitallashuvi pieris.com (PVLA)|SVRA: Balans kapitallashuvi|Kompaniyaning xususiy kapitali Rigel Pharma RIGL|Balans kapitallashuvi ANAB (AnaptysBio Corp)|ATXS: Biznesning balans bahosi|ENGN (enGene Holdings Inc.) - Kompaniyaning balans qiymati|RAPT (rapt.com) - Kompaniyaning sof aktivlari|Kompaniyaning balans qiymati JBIO|Kompaniyaning sof aktivlari Aclaris Therapeutics Inc. (ACRS)|Kompaniyaning sof aktivlari KYTX|Balans kapitallashuvi TLSA (Tiziana Life Sciences, Ltd.)|CABA - Kompaniyaning balans qiymati|Buxgalteriya kapitallashuvi ventyxbio.com VTYX|Balans kapitallashuvi THTX (Theratechnologies)|AVTX - Biznesning balans bahosi|ELDN (Eledon) - Balans kapitallashuvi|Kompaniyaning sof aktivlari Agenus, Inc|CLYM - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati zurabio.com|ATYR (aTyr Pharma) - Balans kapitallashuvi|Biznesning balans bahosi ADAG (adagene.com)|IMA - Kompaniyaning balans qiymati|Buxgalteriya kapitallashuvi Shattuck Labs Inc STTK|EQ: Balans kapitallashuvi|Connect Biopharma (CNTB) - Kompaniyaning sof aktivlari|atarabio.com - Kompaniyaning sof aktivlari|InflaRx (IFRX) - Biznesning balans bahosi|XFOR: Balans kapitallashuvi|Biznesning balans bahosi ACET|Kompaniyaning balans qiymati CELU (Celularity Inc.)|Kompaniyaning sof aktivlari inmunebio.com INMB|Kompaniyaning sof aktivlari BRNS (Barinthus Biotherapeutics plc)|KZR - Balans kapitallashuvi|SAB Biotherapeutics, Inc (SABS) - Kompaniyaning sof aktivlari|AKTX: Buxgalteriya kapitallashuvi|Kompaniyaning balans qiymati enlivex.com (ENLV)|Q32 Bio (QTTB) - Sof aktivlar qiymati|GOVX - Balans kapitallashuvi|Kompaniyaning buxgalteriya qiymati Edesa Biotech Inc|Balans kapitallashuvi IBIO|Balans kapitallashuvi CARM (carismatx.com)|Kompaniyaning balans qiymati XTL Biopharmaceuticals|Bolt Biotherapeutics Inc. - Kompaniyaning buxgalteriya qiymati|HCWB: Kompaniyaning balans qiymati|APVO - Kompaniyaning sof aktivlari|AIM: Balans kapitallashuvi|Balans kapitallashuvi Aditxt, Inc.|GRI - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati xortx.com|HIND (Vyome Holdings) - Balans kapitallashuvi|Biznesning balans bahosi REVB (Revelation Biosciences Inc)|Indaptus - Kompaniyaning balans qiymati|BiondVax Pharmaceuticals - Kompaniyaning sof aktivlari|CALI: Kompaniyaning balans qiymati|Affimed (AFMD) - Kompaniyaning sof aktivlari|ALLK: Kompaniyaning sof aktivlari|HOOK (HOOKIPA Pharma) - Balans kapitallashuvi|Kompaniyaning balans qiymati IGM Biosciences Inc. (IGMS)|Buxgalteriya kapitallashuvi iTeos Pharma|Ocean Biomedical, Inc. - Balans kapitallashuvi|Kompaniyaning xususiy kapitali tcbiopharm.com (TCBP)|Balans kapitallashuvi THRD